VHL
VITASORA HEALTH LIMITED
$0.0110
▼ -8.33%
Market cap
$26M
Turnover
$56,500
Last price
$0.0110
Day change
-8.33%
Announcements
13
Range, past year
Open 0.025 · Low 0.009 · Now 0.011 · High 0.047
Open VHL in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
VHL momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-11-16.
Momentum quality
16/100
Wyckoff phase
Accumulation25d
Trend stage
Neutral
1 Day
-8.3%
1 Week
+0.0%
1 Month
+0.0%
1 Year
-57.7%
RSI
43
Avg daily range
9.1%
VITASORA HEALTH LIMITED scores 16 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 25 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -31.2%
- High volatility (ATR 9.1%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
VHL announcements
Recent price-sensitive releases.
- 2026-11-09 VHL CCM Patients Outperform Benchmarks, Enhancing Growth Progress Report
- 2026-10-30 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
- 2026-10-30 VHL Secures Major Contract and $3m Working Capital Facility Progress Report | Debt Facility
- 2026-10-29 Notice of Annual General Meeting/Proxy Form Capital Reconstruction | Notice of Annual General Meeting | Proxy Form | Letter to Shareholders
- 2026-10-06 Vitasora Market Update Presentation - October 2026 Company Presentation
- 2026-08-28 June 2026 Appendix 4E Preliminary Final Report
- 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
More Health Care stocks
Most traded in the same sector.